188 related articles for article (PubMed ID: 8176852)
41. Philadelphia chromosome negative acute lymphoblastic leukemia preceding Philadelphia positive chronic myelogenous leukemia.
Hörnsten P; Nordenson I; Wahlin A
Cancer Genet Cytogenet; 1989 Jun; 39(2):147-52. PubMed ID: 2752368
[TBL] [Abstract][Full Text] [Related]
42. [Hypercalcemia mediated by parathyroid hormone-related protein in the blastic phase of chronic myelogenous leukemia].
Kakihana K; Mizuchi D; Yamaguchi M; Sakashita C; Fukuda T; Yamamoto K; Miki T; Tohda S; Koyama T; Murakami N; Miura O
Rinsho Ketsueki; 2002 Feb; 43(2):102-6. PubMed ID: 11925871
[TBL] [Abstract][Full Text] [Related]
43. [Chronic myelogenous leukemia characterized by successive lymphoid and myelomonocytic blast crises].
Shirai T; Hasegawa S; Niitani K; Nishimura T; Ishida H; Shinohara T
Rinsho Ketsueki; 1989 May; 30(5):668-73. PubMed ID: 2795881
[TBL] [Abstract][Full Text] [Related]
44. Gene expression profiling of CD34+ cells identifies a molecular signature of chronic myeloid leukemia blast crisis.
Zheng C; Li L; Haak M; Brors B; Frank O; Giehl M; Fabarius A; Schatz M; Weisser A; Lorentz C; Gretz N; Hehlmann R; Hochhaus A; Seifarth W
Leukemia; 2006 Jun; 20(6):1028-34. PubMed ID: 16617318
[TBL] [Abstract][Full Text] [Related]
45. Aberrant expression of the LHX4 LIM-homeobox gene caused by t(1;14)(q25;q32) in chronic myelogenous leukemia in biphenotypic blast crisis.
Yamaguchi M; Yamamoto K; Miura O
Genes Chromosomes Cancer; 2003 Nov; 38(3):269-73. PubMed ID: 14506703
[TBL] [Abstract][Full Text] [Related]
46. [Discrepancy in karyotypes between peripheral blood and bone marrow during blastic crisis in chronic myelocytic leukemia].
Maeda T; Ashie T; Kikuiri K; Ishiyama N; Takakura M
Rinsho Ketsueki; 1989 Jul; 30(7):1032-6. PubMed ID: 2810787
[TBL] [Abstract][Full Text] [Related]
47. [Chromosomal abnormalities in 38 CML cases of various phases].
Su XY; Cao Q; He KL
Zhonghua Yi Xue Za Zhi; 1999 Jan; 79(1):34-7. PubMed ID: 11601004
[TBL] [Abstract][Full Text] [Related]
48. [Expression of bcl-2 gene in the evolution of chronic myelogenous leukemia to blast crisis and its implication].
Sui X; Su L; Chu J
Zhonghua Xue Ye Xue Za Zhi; 1999 Jan; 20(1):27-9. PubMed ID: 11498840
[TBL] [Abstract][Full Text] [Related]
49. [Treatment of CML with blastic crisis by the combination therapy of VP and low-dose Ara-C].
Chou T; Wakabayashi M; Hayashi N; Arakawa M
Rinsho Ketsueki; 1992 Sep; 33(9):1263-7. PubMed ID: 1433949
[TBL] [Abstract][Full Text] [Related]
50. [A case of chronic myelogenous leukemia presenting multiple extramedullary tumors localized in cranial dura].
Kumagai T; Morimoto K; Tsuboi I; Saitoh T; Aikawa S; Kaneita Y; Ohsima T; Sawada U; Horie T
Rinsho Ketsueki; 1999 Mar; 40(3):224-9. PubMed ID: 10222630
[TBL] [Abstract][Full Text] [Related]
51. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
[TBL] [Abstract][Full Text] [Related]
52. High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia.
Carella AM; Chimirri F; Podestà M; Pitto A; Piaggio G; Dejana A; Lerma E; Pollicardo N; Vassallo F; Soracco M; Benvenuto F; Valbonesi M; Carlier P; Vimercati R; Prencipe E; Gatti AM; Ferrara RA; Incagliato M; Florio G; Frassoni F
Bone Marrow Transplant; 1996 Feb; 17(2):201-5. PubMed ID: 8640167
[TBL] [Abstract][Full Text] [Related]
53. Sudden extramedullary T-lymphoblastic blast crisis in chronic myelogenous leukemia: a nonrandom event associated with imatinib?
Kim AS; Goldstein SC; Luger S; Van Deerlin VM; Bagg A
Am J Clin Pathol; 2008 Apr; 129(4):639-48. PubMed ID: 18343792
[TBL] [Abstract][Full Text] [Related]
54. The onset of CML in blastic crisis: molecular features.
Gregorini A; Filippetti A; Luchetti F; Walker A; Lillington DM; Papa S; Valentini M
J Biol Regul Homeost Agents; 1997; 11(3):111-4. PubMed ID: 9498160
[TBL] [Abstract][Full Text] [Related]
55. Chromosomal abnormalities in Philadelphia chromosome-negative metaphases appearing during imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase.
Medina J; Kantarjian H; Talpaz M; O'Brien S; Garcia-Manero G; Giles F; Rios MB; Hayes K; Cortes J
Cancer; 2003 Nov; 98(9):1905-11. PubMed ID: 14584073
[TBL] [Abstract][Full Text] [Related]
56. [Marrow necrosis as the initial manifestation of a blast crisis in CML].
Guinea JM; Menchaca C; Pérez Clausell C; Aldamiz M
Sangre (Barc); 1992 Feb; 37(1):78-9. PubMed ID: 1585244
[No Abstract] [Full Text] [Related]
57. Simultaneous presence of major secondary chromosomal abnormalities in blast crisis of chronic myeloid leukemia.
Lu CM; Wang E; Lawrence HJ
Cancer Genet Cytogenet; 2007 Jan; 172(2):174-5. PubMed ID: 17213030
[No Abstract] [Full Text] [Related]
58. Lymphoid blast crisis of chronic myelogenous leukemia occurring more than 11 years after receiving an allogeneic bone marrow transplant for chronic myelogenous leukemia in myeloid blast crisis at onset.
Fukuno K; Tsurumi H; Yamada T; Oyama M; Matsuyama T; Terakura S; Kodera Y; Moriwaki H
Bone Marrow Transplant; 2003 Feb; 31(3):211-3. PubMed ID: 12621483
[TBL] [Abstract][Full Text] [Related]
59. Uncommon karyotypic abnormality, t(11;19)(q23;p13.3), in a patient with blastic phase of chronic myeloid leukemia.
Suzuki K; Sugawara T; Kowata S; Utsugizawa T; Ito S; Murai K; Ishida Y
Cancer Genet Cytogenet; 2004 Apr; 150(2):159-63. PubMed ID: 15066325
[TBL] [Abstract][Full Text] [Related]
60. [Clinical efficacy and side effects of STI571 in treatment of patients with chronic myeloid leukemia].
Liu XL; Zhou SY; Du QF; Zheng WY; Zhang S; Song LL; Xu B; Liu QF; Meng FY
Ai Zheng; 2004 Apr; 23(4):421-5. PubMed ID: 15087031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
